Steroids Are Not Recommended for Post-Infectious Glomerulonephritis
Corticosteroids should not be routinely used in post-infectious glomerulonephritis (PIGN), as they provide no proven benefit and significantly increase the risk of serious adverse events, particularly infection-related complications. 1
Key Evidence Against Steroid Use
The most recent and highest quality evidence comes from a 2022 randomized controlled trial that directly addressed this question 2. In 52 patients with biopsy-proven infection-related glomerulonephritis and elevated creatinine:
- No benefit: Complete renal recovery at 6 months occurred in 65.4% with steroids versus 53.8% without steroids (not statistically significant, P=0.397)
- Significant harm: Adverse events occurred in 46.2% of steroid-treated patients versus only 7.7% in controls (P=0.002)
Critical Distinction: Staphylococcal vs. Streptococcal PIGN
The timing of infection matters critically for treatment decisions 3:
- Post-streptococcal GN: True "post-infectious" disease occurring after infection has cleared
- Staphylococcal-related GN: Occurs during active infection, making the term "post-staphylococcal" historically incorrect and clinically misleading
Using steroids during active staphylococcal infection can precipitate severe sepsis and death with no observable benefits 3. This is particularly dangerous because staphylococcal-related GN often presents with IgA-dominant deposits that may tempt clinicians to treat as IgA nephropathy.
Standard Treatment Approach
The cornerstone of PIGN management is supportive care 4, 5:
- Eradicate the infection with appropriate antibiotics
- Manage complications:
- Diuretics for fluid overload
- Antihypertensives for hypertension
- Dialysis if needed for severe AKI
- Monitor closely for resolution (most resolve within 3 months)
Rare Exceptions Where Steroids Might Be Considered
Steroids may have a limited role only in highly specific circumstances 1, 6:
- Crescentic GN with >30% crescents on biopsy
- Progressive renal failure despite aggressive antibiotic therapy AND confirmed eradication of infection
- Multi-organ system deterioration unresponsive to conservative management
Even in these cases, the evidence is anecdotal (case reports only) 7, 6, 8, and the risk-benefit ratio remains uncertain. The KDIGO 2021 guidelines explicitly state that "the utility of immunosuppression, even in cases of crescentic GN, is uncertain and carries substantial potential risks, particularly in the elderly" 1.
Common Pitfalls to Avoid
Do not confuse IgA-dominant PIGN with IgA nephropathy: The presence of IgA deposits in staphylococcal-related GN does not indicate steroid-responsive disease 3
Verify infection clearance before any immunosuppression: Never give steroids during active infection 3, 8
Do not use steroids for typical PIGN: The natural history is excellent with supportive care alone—most children achieve complete recovery 4, 5, 9
Check C3 levels at 12 weeks: Persistently low C3 beyond 12 weeks suggests alternative diagnosis (C3 glomerulonephritis) requiring kidney biopsy 1
Prognosis Without Steroids
The prognosis of PIGN with supportive care alone is generally excellent 1, 4, 5:
- Most patients achieve complete recovery
- Mortality is rare with appropriate supportive management
- Only a small proportion (6.5%) have persistent abnormalities at 3 months 9
Given the lack of proven benefit, significant risk of harm, and excellent prognosis with supportive care alone, steroids should be avoided in routine PIGN management.